Modulating the Expression of IFN Regulatory Factor 8 Alters the Protumorigenic Behavior of CD11b+Gr-1+ Myeloid Cells

  • Stewart T
  • Liewehr D
  • Steinberg S
  • et al.
40Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.
Get full text

Abstract

CD11b+Gr-1+-expressing cells, termed myeloid-derived suppressor cells, can mediate immunosuppression and tumor progression. However, the intrinsic molecular events that drive their protumorigenic behavior remain to be elucidated. Although CD11b+Gr-1+ cells exist at low frequencies in normal mice, it also remains unresolved whether they are biologically distinct from those of tumor-bearing hosts. These objectives were investigated using CD11b+Gr-1+ cells from both implantable (4T1) and autochthonous (mouse mammary tumor virus-polyomavirus middle T Ag (MMTV-PyMT)) mouse models of mammary carcinoma. Limited variation was observed in the expression of markers associated with immunoregulation between CD11b+Gr-1+ cells of both tumor models, as well as with their respective controls (Cnt). Despite limited differences in phenotype, tumor-induced CD11b+Gr-1+ cells were found to produce a more immunosuppressive cytokine profile than that observed by Cnt CD11b+Gr-1+ cells. Furthermore, when admixed with tumor cells, CD11b+Gr-1+ cells from tumor-bearing mice significantly enhanced neoplastic growth compared with counterpart cells from Cnt mice. However, the protumorigenic behavior of these tumor-induced CD11b+Gr-1+ cells was significantly diminished when the expression of IFN regulatory factor 8, a key myeloid-associated transcription factor, was enhanced. The loss of this protumorigenic effect occurred independently of the host immune system and correlated with a CD11b+Gr-1+ cytokine/chemokine production pattern that resembled cells from nontumor-bearing Cnt mice. Overall, our data indicate that 1) tumor-induced CD11b+Gr-1+ cells from both cancer models were phenotypically similar, but biologically distinct from their nontumor-bearing counterparts and 2) modulation of IFN regulatory factor 8 levels in tumor-induced CD11b+Gr-1+ cells can significantly abrogate their protumorigenic behavior, which may have important implications for cancer therapy.

Cite

CITATION STYLE

APA

Stewart, T. J., Liewehr, D. J., Steinberg, S. M., Greeneltch, K. M., & Abrams, S. I. (2009). Modulating the Expression of IFN Regulatory Factor 8 Alters the Protumorigenic Behavior of CD11b+Gr-1+ Myeloid Cells. The Journal of Immunology, 183(1), 117–128. https://doi.org/10.4049/jimmunol.0804132

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free